Literature DB >> 2933466

Two independent pathways of helper activity provided by a single T cell clone.

M Shigeta, S Takahara, S J Knox, T Ishihara, E S Vitetta, C G Fathman.   

Abstract

Data presented in this paper demonstrate the existence of two separate pathways by which a single T cell clone can induce B cell differentiation. With the use of high doses of antigen, a T cell clone can induce a primary antibody response in unprimed B cells. With the use of low doses of antigen, the same T cell clone can induce an immunoglobulin (Ig)G response in primed B cells. The primary response is accompanied by T cell proliferation and lymphokine production (interleukin 2, B cell growth factor, B cell differentiation factor for immunoglobulin M, and B cell differentiation factor for immunoglobulin G). The secondary response does not require proliferation and occurs independently of detectable lymphokine production. Variants of the wild type T cell helper clone have been isolated. One variant can provide help to unprimed B cells when high doses of antigen are used. This variant cannot provide help to primed B cells when low doses of antigen are used, nor can it provide help to CBA/N "xid" B cells at any antigen concentration tested. Additional variants have been isolated that proliferate on antigen-pulsed-presenting cells, but fail to secrete detectable lymphokines and do not induce B cell differentiation. These results suggest that a single T cell helper clone has multiple functional activities that can be independently expressed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2933466

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Interleukin-3 production as a sensitive measure of T-lymphocyte activation in the mouse.

Authors:  E N Dotsika; C J Sanderson
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

2.  Administration in vivo of recombinant interleukin 2 protects mice against septic death.

Authors:  C Weyand; J Goronzy; C G Fathman; P O'Hanley
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

3.  Administration of recombinant interleukin 2 in vivo induces a polyclonal IgM response.

Authors:  C M Weyand; J Goronzy; M J Dallman; C G Fathman
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

4.  Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.

Authors:  J Goronzy; C M Weyand; C G Fathman
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.